ImmunityBio recently reported positive clinical data from its ANKTIVA (nogapendekin alfa inbakicept) program in non-small ...
Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...
Biological age tests measure how fast your body is aging compared to your actual age. These tests rely on biomarkers tied to ...
New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...
Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...
The collaboration enables seamless integration of Owkin's advanced pathology analysis capabilities into Claude's AI platform, ...
"Across the GCC there's a hunger for measurable and science-backed longevity. People want data, they want speed, and they act on it," says wellness expert Aly Rahimtoola ...
Spear Bio joins collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and ...
The Phase 2a trial enrolled 35 IPF patients randomized in a 2:1 ratio to receive either GRI-0621 or placebo once daily for 12 weeks. A sub-study examined immune cells in bronchoalveolar lavage fluid ...
The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...
Converge Bio CEO Dov Gertz said, "The conversation needs to shift from models to AI systems. Unlike ChatGPT, you can’t simply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results